|
SRRM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.8900000028147E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.48600000082766E-08 |
| Normal-vs-Stage2 |
1.854400E-02 |
| Normal-vs-Stage3 |
1.496990E-03 |
| Normal-vs-Stage4 |
3.161700E-02 |
| Stage1-vs-Stage2 |
3.582800E-01 |
| Stage1-vs-Stage3 |
3.535400E-01 |
| Stage1-vs-Stage4 |
2.962200E-02 |
| Stage2-vs-Stage3 |
9.053000E-01 |
| Stage2-vs-Stage4 |
4.391200E-01 |
| Stage3-vs-Stage4 |
2.929600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75670000055217E-07 |
| Normal-vs-AfricanAmerican |
9.448900E-04 |
| Normal-vs-Asian |
5.197800E-02 |
| Caucasian-vs-AfricanAmerican |
3.972400E-01 |
| Caucasian-vs-Asian |
1.385430E-01 |
| AfricanAmerican-vs-Asian |
3.025200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.818700E-04 |
| Normal-vs-Female |
1.01350039471981E-10 |
| Male-vs-Female |
4.215200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.698400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.39210000380675E-08 |
| Normal-vs-Age(61-80Yrs) |
2.35530000000095E-05 |
| Normal-vs-Age(81-100Yrs) |
1.634210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.348600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.856600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.823800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.210400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.636000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.719400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.26919999999353E-05 |
| Normal-vs-Grade 2 |
2.30940000456314E-08 |
| Normal-vs-Grade 3 |
1.401840E-04 |
| Normal-vs-Grade 4 |
2.589800E-01 |
| Grade 1-vs-Grade 2 |
5.817900E-03 |
| Grade 1-vs-Grade 3 |
6.36539999999686E-05 |
| Grade 1-vs-Grade 4 |
2.65980000002664E-06 |
| Grade 2-vs-Grade 3 |
4.414100E-02 |
| Grade 2-vs-Grade 4 |
1.257770E-03 |
| Grade 3-vs-Grade 4 |
7.846300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.0151002260983E-10 |
| Normal-vs-ccB subtype |
1.337700E-02 |
| ccA subtype-vs-ccB subtype |
1.358430E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.38569999988903E-07 |
| Normal-vs-N1 |
8.089000E-01 |
| N0-vs-N1 |
2.390400E-02 |
|
|
